Department of Information Sciences, School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an 710049, People's Republic of China.
IET Syst Biol. 2014 Apr;8(2):67-73. doi: 10.1049/iet-syb.2013.0040.
Identifying drug-target interactions has been a key step for drug repositioning, drug discovery and drug design. Since it is expensive to determine the interactions experimentally, computational methods are needed for predicting interactions. In this work, the authors first propose a single-view penalised graph (SPGraph) clustering approach to integrate drug structure and protein sequence data in a structural view. The SPGraph model does clustering on drugs and targets simultaneously such that the known drug-target interactions are best preserved in the clustering results. They then apply the SPGraph to a chemical view with drug response data and gene expression data in NCI-60 cell lines. They further generalise the SPGraph to a multi-view penalised graph (MPGraph) version, which can integrate the structural view and chemical view of the data. In the authors' experiments, they compare their approach with some comparison partners, and the results show that the SPGraph could improve the prediction accuracy in a small scale, and the MPGraph can achieve around 10% improvements for the prediction accuracy. They finally give some new targets for 22 Food and Drug Administration approved drugs for drug repositioning, and some can be supported by other references.
鉴定药物-靶标相互作用一直是药物重定位、药物发现和药物设计的关键步骤。由于实验确定相互作用的成本高昂,因此需要计算方法来预测相互作用。在这项工作中,作者首先提出了一种单视图惩罚图(SPGraph)聚类方法,用于在结构视图中整合药物结构和蛋白质序列数据。SPGraph 模型对药物和靶点同时进行聚类,使得已知的药物-靶标相互作用在聚类结果中得到最好的保留。然后,他们将 SPGraph 应用于包含 NCI-60 细胞系中药物反应数据和基因表达数据的化学视图。他们进一步将 SPGraph 推广到多视图惩罚图(MPGraph)版本,该版本可以整合数据的结构视图和化学视图。在作者的实验中,他们将他们的方法与一些比较伙伴进行了比较,结果表明 SPGraph 可以提高小规模的预测准确性,而 MPGraph 可以将预测准确性提高约 10%。最后,他们为 22 种食品和药物管理局批准的药物提供了药物重定位的新靶标,其中一些可以得到其他参考文献的支持。